ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 67 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,647,000 | -52.5% | 1,150,000 | -48.9% | 0.02% | -52.8% |
| Q2 2021 | $11,887,000 | +59.2% | 2,251,255 | +114.4% | 0.05% | +55.9% |
| Q1 2019 | $7,466,000 | -65.9% | 1,050,000 | -59.1% | 0.03% | -68.2% |
| Q4 2018 | $21,917,000 | -55.2% | 2,566,386 | +5.0% | 0.11% | -47.0% |
| Q3 2018 | $48,923,000 | -16.6% | 2,443,700 | +7.6% | 0.20% | -13.7% |
| Q2 2018 | $58,689,000 | +20.6% | 2,272,115 | +11.6% | 0.23% | +15.3% |
| Q1 2018 | $48,675,000 | -31.9% | 2,036,600 | -3.5% | 0.20% | -34.3% |
| Q4 2017 | $71,489,000 | +297.2% | 2,109,455 | +148.1% | 0.31% | +286.2% |
| Q3 2017 | $17,998,000 | +795.0% | 850,165 | +639.3% | 0.08% | +627.3% |
| Q2 2017 | $2,011,000 | +119.8% | 115,000 | +119.9% | 0.01% | +120.0% |
| Q1 2017 | $915,000 | -67.1% | 52,300 | -68.2% | 0.01% | -73.7% |
| Q4 2016 | $2,779,000 | +29.7% | 164,450 | +26.0% | 0.02% | +26.7% |
| Q3 2016 | $2,142,000 | -1.6% | 130,500 | -9.2% | 0.02% | 0.0% |
| Q2 2016 | $2,176,000 | +207.3% | 143,700 | +432.2% | 0.02% | +200.0% |
| Q2 2015 | $708,000 | – | 27,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 984,329 | $6,999,000 | 4.03% |
| Broadfin Capital, LLC | 2,469,894 | $17,561,000 | 3.63% |
| Healthcare Value Capital, LLC | 100,000 | $711,000 | 2.74% |
| ARMISTICE CAPITAL, LLC | 2,744,000 | $19,510,000 | 1.07% |
| DELTEC ASSET MANAGEMENT LLC | 536,836 | $3,817,000 | 0.84% |
| SECTORAL ASSET MANAGEMENT INC | 808,924 | $5,751,000 | 0.69% |
| Mosaic Family Wealth, LLC | 91,314 | $649,000 | 0.26% |
| Worth Venture Partners, LLC | 59,740 | $425,000 | 0.24% |
| EMERALD ADVISERS, LLC | 626,247 | $4,453,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 565,319 | $4,019,000 | 0.16% |